On 22 December 2025, the US Food and Drug Administration (FDA) approved the Wegovy® pill (oral semaglutide 25 mg tablet) as the first oral GLP-1 receptor agonist for chronic weight management. Indica...

Cardiac conditions such as heart failure, stroke, and artery disease are major killers across the globe. Lowering blood sugar levels has been the focus for many years for diabetic patients, but ne...